Matches in SemOpenAlex for { <https://semopenalex.org/work/W3088981794> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W3088981794 abstract "In our study, in addition to prescribing a high dose of oxytocin nasal, we were attempting to non-drug activities in group, for prevent of V1 vasopressin receptor cross reactivity at higher OT dosages .This study was a double-blind clinical trial.that 60 men, all with methadone use, stopped their methadone and entered the 72-hour marathon group(or individually) on the second day, randomly receiving oxytocin or placebo. We compared the subjects in four groups. - Prescribing nasal: 1 oxytocin as individually. 2. placebo as individually. 3. placebo in Marathon group. 4. oxytocin in marathon group .We measured the mean of each withdrawal sign on day 2, 3, and 4 after methadone discontinuation . we understood that those who took oxytocin sprays in the marathon group with group activities that enhance group empathy, withdrawal symptoms and craving after discontinuation of methadone would be less than other groups., and this was not related to the age of people and the amount of methadone that they consumed. These peoples participated more in the grouptherapy and continued that for a longer period. In 3tesla fmri for all subjects (In the two subgroups administration of oxytocin as a group or placebo as a group)were showed images of substances or methadone (called act) and neuter images in the form of a Block task..Activity of Sensory and motor centers, (SMG, PCC, IPL, and SPL, all involved in the temptation and automatic addictive behaviors) reduced by oxytocin. Patients who discontinued methadone in this study and engaged in nonpharmacological activities, such as listening to music, group dance , etc., decreased their self-reflection following oxytocin use .becouse precuneus and pcc,( which can induce selfreflection), decreased their activity due to oxytocin use" @default.
- W3088981794 created "2020-10-01" @default.
- W3088981794 creator A5019646318 @default.
- W3088981794 date "2020-01-01" @default.
- W3088981794 modified "2023-09-27" @default.
- W3088981794 title "Evaluation of nasal oxytocin spray efficacy in reducing withdrawal sign and craving and relapse when cutting Methadone in opioids addicted people that have received Methadone" @default.
- W3088981794 hasPublicationYear "2020" @default.
- W3088981794 type Work @default.
- W3088981794 sameAs 3088981794 @default.
- W3088981794 citedByCount "0" @default.
- W3088981794 crossrefType "journal-article" @default.
- W3088981794 hasAuthorship W3088981794A5019646318 @default.
- W3088981794 hasConcept C118552586 @default.
- W3088981794 hasConcept C126322002 @default.
- W3088981794 hasConcept C142724271 @default.
- W3088981794 hasConcept C15744967 @default.
- W3088981794 hasConcept C204787440 @default.
- W3088981794 hasConcept C27081682 @default.
- W3088981794 hasConcept C2776176026 @default.
- W3088981794 hasConcept C2778715236 @default.
- W3088981794 hasConcept C2778767360 @default.
- W3088981794 hasConcept C2779541405 @default.
- W3088981794 hasConcept C42219234 @default.
- W3088981794 hasConcept C48856860 @default.
- W3088981794 hasConcept C71924100 @default.
- W3088981794 hasConceptScore W3088981794C118552586 @default.
- W3088981794 hasConceptScore W3088981794C126322002 @default.
- W3088981794 hasConceptScore W3088981794C142724271 @default.
- W3088981794 hasConceptScore W3088981794C15744967 @default.
- W3088981794 hasConceptScore W3088981794C204787440 @default.
- W3088981794 hasConceptScore W3088981794C27081682 @default.
- W3088981794 hasConceptScore W3088981794C2776176026 @default.
- W3088981794 hasConceptScore W3088981794C2778715236 @default.
- W3088981794 hasConceptScore W3088981794C2778767360 @default.
- W3088981794 hasConceptScore W3088981794C2779541405 @default.
- W3088981794 hasConceptScore W3088981794C42219234 @default.
- W3088981794 hasConceptScore W3088981794C48856860 @default.
- W3088981794 hasConceptScore W3088981794C71924100 @default.
- W3088981794 hasLocation W30889817941 @default.
- W3088981794 hasOpenAccess W3088981794 @default.
- W3088981794 hasPrimaryLocation W30889817941 @default.
- W3088981794 hasRelatedWork W1856850049 @default.
- W3088981794 hasRelatedWork W2003209151 @default.
- W3088981794 hasRelatedWork W2016858628 @default.
- W3088981794 hasRelatedWork W2040588419 @default.
- W3088981794 hasRelatedWork W2049149575 @default.
- W3088981794 hasRelatedWork W2049676905 @default.
- W3088981794 hasRelatedWork W2074723518 @default.
- W3088981794 hasRelatedWork W2091784589 @default.
- W3088981794 hasRelatedWork W2097221896 @default.
- W3088981794 hasRelatedWork W2103394537 @default.
- W3088981794 hasRelatedWork W2104967950 @default.
- W3088981794 hasRelatedWork W2106952430 @default.
- W3088981794 hasRelatedWork W2151471953 @default.
- W3088981794 hasRelatedWork W2153949323 @default.
- W3088981794 hasRelatedWork W2369594366 @default.
- W3088981794 hasRelatedWork W2419175451 @default.
- W3088981794 hasRelatedWork W2624396785 @default.
- W3088981794 hasRelatedWork W3099145359 @default.
- W3088981794 hasRelatedWork W3119974234 @default.
- W3088981794 hasRelatedWork W2188139727 @default.
- W3088981794 isParatext "false" @default.
- W3088981794 isRetracted "false" @default.
- W3088981794 magId "3088981794" @default.
- W3088981794 workType "article" @default.